ロード中...
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
We quantified human epidermal growth factor receptor 2 (HER2) RNA and protein expression in 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) in situ hybridization (ISH) group 4 (HER2/centromeric probe 17 (CEP17) ratio <2.0, average HER2 copy number ≥4.0 and &...
保存先:
| 出版年: | NPJ Breast Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6715641/ https://ncbi.nlm.nih.gov/pubmed/31482108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0122-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|